Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T01:47:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-02T21:55:42.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new addition has been made on January 20, 2025, while content was removed on December 24, 2024.
    Difference
    1.0%
    Check dated 2025-01-26T16:04:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T11:57:29.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T06:44:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A new addition was made on December 24, 2024, while a deletion occurred on November 18, 2024.
    Difference
    0.6%
    Check dated 2024-12-28T19:56:04.000Z thumbnail image

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.